The latest news from Indian pharm and healthcare, including Piramal Enterprises’ decision to demerge and list its pharma arm, the country’s 15…

The latest news from Russian healthcare and life sciences, including the WHO’s decision to suspend the approval process for the country’s Sputnik…

The latest news from Chinese pharma and biotech, including news that state-owned Sinopharm is now developing its own mRNA vaccine; an update on Hong…

The latest pharma news from Central and Eastern Europe (CEE), including a new report on the disparities between the region’s healthcare systems and…

A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock Ingram’s full year profit drop, and…

The latest news from Chinese pharma, including Fosun Pharma’s 2021 interim results; how AstraZeneca, Bayer, Eli Lilly, Merck & Co., Novartis,…

The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch & Lomb’s EUR 90 million…

The latest from Spanish pharma, including the Patent and Trademark Office’s warning of the importance of IP protection for medical advancements,…

The latest news from the Chinese pharmaceutical industry, including recent deals between domestic pharma giant Simcere and German biotech Vivoryon in…

The latest from US health care policy, including the Senate budget deal funding for a range of major health care priorities; Biden’s proposed…

The latest from South African pharma, including President Ramaphosa’s blunt criticism of Big Pharma, Aspen’s reception of USD 700 million in…

The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated regional strategy; a pandemic-induced…